Reprogramming of Nucleotide Metabolism in Cardiovascular Inflammation Linked to Obesity: A Novel Insight

• by Taoming Qian, Meijun Zhang, Yuhan Liu, Donghao Guo, Juan Jin

• April 24, 2026

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

• by Kathryn Wighton

• May 27, 2026

• 5 min

Editorial: Cardiovascular Anthropometry For Large Scale Population Studies Volume II

• by Basil N. Okeahialam, Okechukwu S. Ogah

• May 28, 2026

Association Between Metabolic Clusters and Microbial Age in High-Risk Populations for Diabetes and Their Potential Impact on Cardiovascular Disease Risk: Cross-Sectional Observational Study

• by Lu Xinlin, Hongli Gu, Ren Li, Xianjun Mao, Can Chen

• May 26, 2026